How Bugs Make Lassos  by Rosengren, K. Johan & Craik, David J.
Chemistry & Biology
PreviewsHow Bugs Make LassosK. Johan Rosengren1 and David J. Craik1,*
1The University of Queensland, Institute for Molecular Bioscience, Brisbane, QLD 4072, Australia
*Correspondence: d.craik@imb.uq.edu.au
DOI 10.1016/j.chembiol.2009.12.004
In this issue of Chemistry & Biology, Knappe et al. report the generation of a series of mutants of the bacterial
peptide capistruin to help unravel key aspects of the biosynthesis of its unusual lasso structure.Lasso peptides are a structurally unique
family of ribosomally synthesized natural
products produced by certain bacteria
to defend against competing strains
(Rebuffat et al., 2004; Severinov et al.,
2007). They are characterized by an 8- or
9-residue macrolactam ring formed
through the crosslinking of their N-ter-
minal amino group with the side-chain
carboxyl of a glutamic- or aspartic-acid
residue. Remarkably, the remaining C-ter-
minal tail segment is threaded through this
ring, resulting in the lasso-like arrange-
ment that has given the family its name.
Unfolding of this threaded structure is pre-
ventedby bulky amino acids on both sides
of the ring, making the fold exceptionally
stable. So far, six peptides have been
found to adopt such a structure and they
have been divided into class I and class II
lasso peptides based on the presence or
absence of two disulfide bonds, respec-
tively, in addition to the threaded noose.
Capistruin is a 19-residue class II lasso
peptide encoded by the capABCD gene
cluster in the pathogenic bacterium Bur-
kholderia thailandensis (Knappe et al.,
2008). It was discovered through genome
mining studies that identified homology
between each of the four genes in the
capABCD cluster and the corresponding
four plasmid encoded genes mcjABCD,
which are responsible for producing the
related microcin J25 in Escherichia coli.
The cluster encodes the 47 residue
precursor protein CapA, two processing
enzymes, CapB and CapC, which are
responsible for the maturation of the
CapA precursor, and CapD, which is
homologous to ABC transporters and
required for export and self-immunity.
CapB and CapC are weakly homologous
to bacterial transglutaminase and aspara-
gine synthetase B, respectively. It is
proposed that during capistruin matura-
tion, CapB cleaves the CapA precursorto free the Gly1 N terminus, and CapC
activates the side-chain carboxyl group
of Asp9 to promote the condensation
reaction. The tight threading of the
C-terminal tail through the macrolactam
ring in mature capistruin means the
CapA precursor has to be folded correctly
beforehand, so that the ring is enclosed
around the C-terminal tail. Mature
capistruin has potent antimicrobial
activity on Burkholderia and Pseudo-
monas strains that are closely related to
B. thailandensis.
In the featured article, the authors sys-
tematically modified the CapA precursor
to decipher the requirements for it to
interact with, and be folded and secreted
by the CapB, CapC, and CapD system.
Using an elegantly designed expression
system in E. coli, they made 48 mutated
variants of the precursor protein and
investigated their ability to be processed
into mature capistruin (Knappe et al.,
2009). The mutations included an Ala-
scan of all residues in the mature domain
and the proximal residues upstream in the
prosequence, as well as variants probing
the implications of extending or truncating
the C-terminal tail or the N-terminal ring.
Strikingly, the capistruin sequence was
readily amenable to changes, with most
variants folding correctly. Exceptions
included a tri-peptide region (Arg11-
Val12-Ile13) near the critical aspartic
acid at position 9 and a single residue in
the prodomain, Thr27, which are presum-
ably critical for recognition by the CapB
and CapC processing enzymes. Changes
to the N-terminal ring, either by the addi-
tion or the deletion of a residue, or by
changing the critical cross-linked Asp9
to a Glu, are not tolerated, and all such
variants do not fold correctly. In contrast,
the C-terminal tail can be extended by
one residue, or truncated by up to three
residues, without disruption to the folding.Chemistry & Biology 16, December 24, 2009 ªFurthermore, double and triple mutations
of bulky residues in the C-terminal
segments were produced to investigate
the role of Arg15, Phe16, and Phe18 in
preventing the unfolding of the precursor.
Interestingly, Arg15 was found to be the
key residue for keeping the C-terminal
tail trapped. The finding that only a small
subset of amino acids is required for
correct folding is consistent with studies
on microcin J25; however, for microcin
J25, key residues are located in the
N-terminal ring and the threaded segment
rather than the loop (Pavlova et al., 2008).
The lasso peptides share some features
with another family of peptides having a
complex topology, namely the cyclotides
from plants (Craik, 2006). Cyclotides
have their N and C termini linked by a
peptide bond, creating a seamless pep-
tide backbone with no beginning or end.
During the initial characterization of a
lasso peptide microcin J25, it was mistak-
enly believed to be a head-to-tail cyclic
peptide like thecyclotides, inpart because
it could be enzymatically digested without
dissociation into two peptide fragments
(Rebuffat et al., 2004). It was subsequently
shown that this is because the N-terminal
ring in microcin J25 wraps so tightly
around the C-terminal tail that the frag-
ments can not be separated under stan-
dard analytical conditions (Rosengren
et al., 2003; Bayro et al., 2003; Wilson
et al., 2003). Thus the initial comparison
with cyclotides was flawed, but when the
lasso structure was revealed, so was
a similarity in threading. In addition to their
cyclic backbone, cyclotides contain
a cystine knot inwhich twodisulfidebonds
and the interconnectingbackbone forman
embedded ring that is threaded by a third
disulfide bond. Figure 1 shows a com-
parison of the cores of microcin J25,
capistruin, and the prototypic cyclotide
kalata B1.2009 Elsevier Ltd All rights reserved 1211
Figure 1. Threaded and Knotted Peptides
The lasso peptides capistruin andmicrocin J25 from bacteria, and the cyclotide
kalata B1 from plants, share similar features in that the small b sheets are stabi-
lized by topologically restricting covalent crosslinks to form ultra-stable struc-
tures (upper panel). A key feature of all of these peptides is a tightly threaded
embedded ring (lower panel); in the lasso peptides, the peptide backbone itself
passes through the ring, whereas in the cyclotides a disulfide bond threads the
ring to form a cystine knot. The cyclotides have the additional feature of a head-
to-tail cyclised backbone (ligation point indicated by an arrow).
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plex peptides so interesting?
Naturally, their interlocked
structures are intriguing in
their own right and raise
questions about the mecha-
nisms of folding and pro-
cessing that are nicely ad-
dressed in the study by
Knappe et al. (2009). But
the most striking common
feature of these peptides is
their unique chemical and
biological stability. Lassos
and cyclotides are extremely
resistant to proteolytic
degradation or denaturation
by heat, and in many ways
behave more like small
organic molecules than pro-
teins, thus raising the possi-
bility that the poor stability
typically associated with
peptide-based drug leads
might be overcome using
these novel topologies (Clark
et al., 2005). The character-
ization of the requirements
for correct folding of capi-
struin by Knappe et al.(2009) demonstrates that there is scope
for new modifications of the peptide se-
quence to optimize its antibiotic spec-
trum or, we believe, to introduce epitopes
with new bioactivities. This paves the way
for future exploration of capistruin and1212 Chemistry & Biology 16, December 24,other lasso peptides as templates for
drug development. The noose that
bacteria use to strangle their com-
petitors might thus turn out to be a
beneficial rope trick in pharmaceutical
design.2009 ª2009 Elsevier Ltd All rights reservedREFERENCES
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